Skip to main content

Advertisement

Log in

Investigation of the Possible Functions of PACAP in Human Trophoblast Cells

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) is an endogenous neuropeptide having a widespread distribution both in the nervous system and peripheral organs including the female reproductive system. Both the peptide and its receptors have been shown in the placenta but its role in placental growth, especially its human aspects, remains unknown. The aim of the present study was to investigate the effects of PACAP on invasion, proliferation, cell survival, and angiogenesis of trophoblast cells. Furthermore, cytokine production was investigated in human decidual and peripheral blood mononuclear cells. For in vitro studies, human invasive proliferative extravillous cytotrophoblast (HIPEC) cells and HTR-8/SVneo human trophoblast cells were used. Both cell types were used for testing the effects of PACAP on invasion and cell survival in order to investigate whether the effects of PACAP in trophoblasts depend on the examined cell type. Invasion was studied by standardized invasion assay. PACAP increased proliferation in HIPEC cells, but not in HTR-8 cells. Cell viability was examined using MTT test, WST-1 assay, and annexin V/propidium iodide flow cytometry assay. Survival of HTR-8/SVneo cells was studied under oxidative stress conditions induced by hydrogen peroxide. PACAP as pretreatment, but not as co-treatment, significantly increased the number of surviving HTR-8 cells. Viability of HIPEC cells was investigated using methotrexate (MTX) toxicity, but PACAP1-38 could not counteract its toxic effect. Angiogenic molecules were determined both in the supernatant and the cell lysate by angiogenesis array. In the supernatant, we found that PACAP decreased the secretion of various angiogenic markers, such as angiopoietin, angiogenin, activin, endoglin, ADAMTS-1, and VEGF. For the cytokine assay, human decidual and peripheral blood lymphocytes were separated and treated with PACAP1-38. Th1 and Th2 cytokines were analyzed with CBA assay and the results showed that there were no significant differences in control and PACAP-treated cells. In summary, PACAP seems to play various roles in human trophoblast cells, depending on the cell type and microenvironmental influences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Atlasz T, Szabadfi K, Kiss P et al (2010) Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Ann NY Acad Sci 1200:128–139

  • Banki E, Degrell P, Kiss P et al (2013) Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy. Peptides 42:125–130

    Article  CAS  PubMed  Google Scholar 

  • Brubel R, Boronkai A, Reglodi D et al (2010) Changes in the expression of pituitary adenylate cyclase-activating polypeptide in the human placenta during pregnancy and its effects on the survival of JAR choriocarcinoma cells. J Mol Neurosci 42:450–458

    Article  CAS  PubMed  Google Scholar 

  • Boronkai A, Brubel R, Racz B et al (2009) Effects of pituitary adenylate cyclase activating polypeptide on the survival and signal transduction pathways in human choriocarcinoma cells. Ann N Y Acad Sci 1163:353–357

  • Burton GJ, Jauniaux E (2004) Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 11:342–352

    Article  CAS  PubMed  Google Scholar 

  • Csanaky K, Doppler W, Tamas A, Kovacs K, Toth G, Reglodi D (2014) Influence of terminal differentiation and PACAP on the cytokine, chemokine, and growth factor secretion of mammary epithelial cells. J Mol Neurosci 52:28–36

    Article  CAS  PubMed  Google Scholar 

  • D'Amico AG, Scuderi S, Saccone S, Castorina A, Drago F, D'Agata V (2013) Antiproliferative effects of PACAP and VIP in serum-starved glioma cells. J Mol Neurosci 51:503–513

    Article  PubMed  Google Scholar 

  • Fabian E, Reglodi D, Mester L et al (2012) Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress. J Mol Neurosci 48:493–500

    Article  CAS  PubMed  Google Scholar 

  • Ganea D, Delgado M (2002) Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) as modulators of both innate and adaptive immunity. Crit Rev Oral Biol Med 13:229–237

    Article  PubMed  Google Scholar 

  • Gasz B, Racz B, Roth E et al (2006) Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis. Peptides 27:87–94

    Article  CAS  PubMed  Google Scholar 

  • Grasso E, Paparini D, Auero M, Mor G, Perez Leiros C, Ramhorst R (2014) VIP contribution to the decidualization program: regulatory T cell recruitment. J Endocrinol 221:121–31

  • Horvath G, Reglodi D, Opper B et al (2010) Effects of PACAP on the oxidative stress-induced cell death in chicken pinealocytes is influenced by the phase of the circadian clock. Neurosci Lett 484:148–152

    Article  CAS  PubMed  Google Scholar 

  • Horvath G, Brubel R, Kovacs K et al (2011) Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells. J Mol Neurosci 43:67–75

  • Isaac ER, Sherwood NM (2008) Pituitary adenylate cyclase activating polypeptide (PACAP) is important for embryo implantation in mice. Mol Cell Endocrinol 280:13–19

    Article  CAS  PubMed  Google Scholar 

  • Ko C, In YH, Park-Sarge OK (1999) Role of progesterone receptor activation in pituitary adenylate cyclase-activating polypeptide gene expression in rat ovary. Endocrinology 140:5185–5194

    CAS  PubMed  Google Scholar 

  • Koh PO, Kwak SD, Kim HJ et al (2003) Expression patterns of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in the rat placenta. Mol Reprod Dev 64:27–31

    Article  CAS  PubMed  Google Scholar 

  • Koh PO, Won CK, Noh HS, Cho CJ, Choi WS (2005) Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta. J Vet Sci 6:1–5

    PubMed  Google Scholar 

  • Köves K, Kántor O, Lakatos A et al. (2014) Advent and recent advances in research on the role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the regulation of gonadotropic hormone secretion of female rats. J Mol Neurosci doi:10.1007/s12031-014-0294-7

  • Laburthe M, Couvineau A (2002) Molecular pharmacology and structure of VPAC receptors for VIP and PACAP. Regul Pept 108:165–173

    Article  CAS  PubMed  Google Scholar 

  • Laburthe M, Couvineau A, Tan V (2007) Class II G protein-coupled receptors for VIP and PACAP: Structure, models of activation and pharmacology. Peptides 28:1631–1639

    Article  CAS  PubMed  Google Scholar 

  • Li M, Cortez S, Nakamachi T, Batuman V, Arimura A (2006) Pituitary adenylate cyclase activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells. Cancer Res 66:8796–8803

    Article  CAS  PubMed  Google Scholar 

  • Lutz EM, MacKenzie CJ, Johnson M et al (1999) Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/PACAP (PAC1) receptors. Br J Pharmacol 128:934–940

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Miyata A, Arimura A, Dahl RR et al (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567–574

    Article  CAS  PubMed  Google Scholar 

  • Muller JM, Debaigt C, Goursaud S et al (2007) Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update. Peptides 28:1655–1666

    Article  CAS  PubMed  Google Scholar 

  • Nakamachi T, Tsuchida M, Kagami N et al (2012) IL-6 and PACAP receptor expression and localization after global brain ischemia in mice. J Mol Neurosci 48:518–525

    Article  CAS  PubMed  Google Scholar 

  • Pavan L, Tarrade A, Hermouet A et al (2003) Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARγ in cell invasion process. Carcinogenesis 24:1325–1336

    Article  CAS  PubMed  Google Scholar 

  • Poston L, Igosheva N, Mistry HD et al (2011) Role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am J Clin Nutr 94:1980S–1985S

    Article  CAS  PubMed  Google Scholar 

  • Racz B, Reglodi D, Horvath G et al (2010) Protective effect of PACAP against doxorubicin-induced cell death in cardiomyocyte culture. J Mol Neurosci 42:419–427

    Article  CAS  PubMed  Google Scholar 

  • Reglodi D, Kiss P, Lubics A, Tamas A (2011) Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des 17:962–972

    Article  CAS  PubMed  Google Scholar 

  • Reglodi D, Kiss P, Szabadfi K et al (2012a) PACAP is an endogenous protective factor-insights from PACAP-deficient mice. J Mol Neurosci 48:482–492

    Article  CAS  PubMed  Google Scholar 

  • Reglodi D, Tamas A, Koppan M, Szogyi D, Welke L (2012b) Role of PACAP in female fertility and reproduction at gonadal level—recent advances. Front Endocrinol (Lausanne) 3:155

    Google Scholar 

  • Scaldaferri ML, Modesti A, Palumbo C et al (2000) Pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta. Endocrinology 141:1158–1167

    CAS  PubMed  Google Scholar 

  • Somogyvari-Vigh A, Reglodi D (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr Pharm Des 10:2861–2889

    Article  CAS  PubMed  Google Scholar 

  • Spencer F, Chi L, Zhu MX (2001a) Temporal relationships among uterine pituitary adenylate cyclase activating polypeptide, decidual prolactin-related protein and progesterone receptor mRNAs expressions during decidualization and gestation in rats. Comp Biochem Physiol C 129:25–34

    CAS  Google Scholar 

  • Spencer F, Chi L, Zhu MX (2001b) A mechanistic assessment of 1,3-butadiene diepoxide-induced inhibition of uterine deciduoma proliferation in pseudopregnant rats. Reprod Toxicol 15:253–260

    Article  CAS  PubMed  Google Scholar 

  • Sreedharan SP, Huang JX, Cheung MC, Goetzl EJ (1995) Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc Natl Acad Sci U S A 92:2939–2943

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Staun-Ram E, Goldman S, Gabarin D, Shalev E (2004) Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2:59

    Article  PubMed Central  PubMed  Google Scholar 

  • Steenstrup BR, Alm P, Hannibal J et al (1995) Pituitary adenylate cyclase-activating polypeptide: occurrence and relaxant effect in female genital tract. Am J Physiol 32:E108–E117

    Google Scholar 

  • Steenstrup BR, Jorgensen JC, Alm P et al (1996) Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence and vasodilatory effect in the human uteroplacental unit. Regul Pept 61:197–204

    Article  CAS  PubMed  Google Scholar 

  • Szabo E, Nemeskeri A, Arimura A, Koves K (2004) Effect of PACAP on LH release studied by cell immunoblot assay depends on the gender, on the time of day and in female rats on the day of the estrous cycle. Regul Pept 123:139–145

    Article  CAS  PubMed  Google Scholar 

  • Szereday L, Miko E, Meggyes M et al (2012) Commitment of decidual haematopoietic progenitor cells in first trimester pregnancy. Am J Reprod Immunol 67:9–16

    Article  CAS  PubMed  Google Scholar 

  • Teng CH, Ke FC, Lee MT, Lin SW, Chen L, Hwang JJ (2000) Pituitary adenylate cyclase-activating polypeptide acts synergistically with relaxin in modulating ovarian cell function in rats. J Endocrinol 167:61–69

    Article  CAS  PubMed  Google Scholar 

  • Vaudry D, Falluel-Morel A, Bourgault S et al (2009) (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283–357

    Article  CAS  PubMed  Google Scholar 

  • Wojcieszak J, Zawilska JB (2014) PACAP38 and PACAP6-38 exert cytotoxic activity against human retinoblastoma Y79 cells. J Mol Neurosci doi:10.1007/s12031-014-0248-0

Download references

Acknowledgments

This study was supported by OTKA K104984, K104960, TAMOP (4.2.2.A-11/1/KONV-2012-0024), the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TÁMOP 4.2.4. A/2-11-1-2012-0001 “National Excellence Program”, Magyary Zoltan Scholarship, Arimura Foundation, PTE-MTA “Lendület” Program, and the Bolyai Scholarship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Reglodi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horvath, G., Reglodi, D., Brubel, R. et al. Investigation of the Possible Functions of PACAP in Human Trophoblast Cells. J Mol Neurosci 54, 320–330 (2014). https://doi.org/10.1007/s12031-014-0337-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-014-0337-0

Keywords

Navigation